Gene · 3777
Papers1,851
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,851
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of potential drug targets for amyotrophic lateral sclerosis by Mendelian randomization analysis based on brain and plasma proteomics. | Exp Gerontol | 2024 | 39116956 | PubTator, text mining | PubMed |
| Multi-omics Mendelian randomization integrating GWAS, eQTL and pQTL data revealed GSTM4 as a potential drug target for migraine. | J Headache Pain | 2024 | 39039470 | PubTator, text mining | PubMed |
| Identifying novel potential drug targets for endometriosis via plasma proteome screening. | Front Endocrinol (Lausanne) | 2024 | 39036049 | PubTator, text mining | PubMed |
| Integrating genetic and proteomic data to elucidate the association between immune system and blood-brain barrier dysfunction with multiple sclerosis risk and severity. | J Affect Disord | 2024 | 39029667 | PubTator, text mining | PubMed |
| Identification of Novel Protein Biomarkers and Drug Targets for Acne Vulgaris by Integrating Human Plasma Proteome with Genome-Wide Association Data. | J Inflamm Res | 2024 | 39006495 | PubTator, text mining | PubMed |
| [Single-cell transcriptomic sequencing coupled with Mendelian randomization analysis elucidates the pivotal role of CTSC in chronic rhinosinusitis]. | Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi | 2024 | 38965845 | PubTator, text mining | PubMed |
| Caffeine Inhibits Both Basal and Insulin-Activated Urate Transport. | Arthritis Rheumatol | 2024 | 38932509 | PubTator, text mining | PubMed |
| The Role of KACh Channels in Atrial Fibrillation. | Cells | 2024 | 38920645 | PubTator, text mining | PubMed |
| Electrophysiological Effects of the Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitor Dapagliflozin on Human Cardiac Potassium Channels. | Int J Mol Sci | 2024 | 38891889 | PubTator, text mining | PubMed |
| Genome-Wide Methylation Analysis Reveals a KCNK3-Prominent Causal Cascade on Hypertension. | Circ Res | 2024 | 38841840 | PubTator, text mining | PubMed |
| Identifying potential drug targets for varicose veins through integration of GWAS and eQTL summary data. | Front Genet | 2024 | 38818040 | PubTator, text mining | PubMed |
| High-throughput functional mapping of variants in an arrhythmia gene, KCNE1, reveals novel biology. | Genome Med | 2024 | 38816749 | PubTator, text mining | PubMed |
| Impact of periodontitis on type 2 diabetes: a bioinformatic analysis. | BMC Oral Health | 2024 | 38811930 | PubTator, text mining | PubMed |
| The TREK-1 potassium channel is a potential pharmacological target for vasorelaxation in pulmonary hypertension. | Br J Pharmacol | 2024 | 38807478 | PubTator, text mining | PubMed |
| Metabolism, Disposition, Excretion, and Potential Transporter Inhibition of 7-16, an Improving 5-HT2A Receptor Antagonist and Inverse Agonist for Parkinson's Disease. | Molecules | 2024 | 38792047 | PubTator, text mining | PubMed |
| Critical reasoning on the co-expression module QTL in the dorsolateral prefrontal cortex. | HGG Adv | 2024 | 38773772 | PubTator, text mining | PubMed |
| A novel method for multiple phenotype association studies based on genotype and phenotype network. | PLoS Genet | 2024 | 38728360 | PubTator, text mining | PubMed |
| Potential therapeutic targets for membranous nephropathy: proteome-wide Mendelian randomization and colocalization analysis. | Front Immunol | 2024 | 38707900 | PubTator, text mining | PubMed |
| Uric acid-lowering effect of harpagoside and its protective effect against hyperuricemia-induced renal injury in mice. | Biochem Biophys Res Commun | 2024 | 38704891 | PubTator, text mining | PubMed |
Survey of Pharmaceutical Industry's Best Practices around In Vitro Transporter Assessment and Implications for Drug Development: Considerations from the International Consortium for Innovation and Quality for Pharmaceutical Development Transporter Working Group. | Drug Metab Dispos | 2024 | 38697852 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3777/papers?page=10